[HTML] mdpi.com

[HTML][HTML] Use of monoclonal antibodies in immunocompromised patients hospitalized with severe COVID-19: a retrospective multicenter cohort

J Calderón-Parra, P Guisado-Vasco… - Journal of clinical …, 2023 - mdpi.com
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …
被引用次数：7 相关文章

[引用][C] Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón-Parra… - Journal of …, 2023 - portalcientifico.universidadeuropea …
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …

Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón-Parra, P Guisado-Vasco… - Journal of Clinical …, 2023 - search.proquest.com
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …
[PDF] academia.edu

[PDF][PDF] Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón-Parra, P Guisado-Vasco… - J. Clin. Med - academia.edu
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …

[引用][C] Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón-Parra… - Journal of Clinical …, 2023 - produccioncientifica.ucm.es

Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort.

J Calderón-Parra, P Guisado-Vasco… - Journal of Clinical …, 2023 - search.ebscohost.com
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …

Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón-Parra, P Guisado-Vasco… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective We aim to describe the safety and efficacy of sotrovimab in severe cases of COVID-
19 in immunocompromised hosts. Methods We used a retrospective multicenter cohort …
[PDF] core.ac.uk

[PDF][PDF] Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón-Parra, P Guisado-Vasco… - J. Clin. Med - core.ac.uk
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …

Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón Parra, P Guisado Vasco… - 2023 - docta.ucm.es
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …
[HTML] nih.gov

[HTML][HTML] Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

J Calderón-Parra, P Guisado-Vasco… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Objective: We aim to describe the safety and efficacy of sotrovimab in severe cases of
COVID-19 in immunocompromised hosts. Methods: We used a retrospective multicenter …